Impact of atypical long-acting injectable versus oral antipsychotics on rehospitalization rates and emergency room visits among relapsed schizophrenia patients: a retrospective database analysis
about
Drug Utilization of Japanese Patients Diagnosed with Schizophrenia: An Administrative Database Analysis.The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal.Efficacy and safety of once-monthly injection of paliperidone palmitate in hospitalized Asian patients with acute exacerbated schizophrenia: an open-label, prospective, noncomparative study.Hospitalization rates in patients switched from oral anti-psychotics to aripiprazole once-monthly: final efficacy analysisTreatment patterns in Medicaid patients with schizophrenia initiated on a first- or second-generation long-acting injectable versus oral antipsychotic.Antipsychotic prescribing of consultant forensic psychiatrists working in different levels of secure care with patients with schizophrenia.Onset and persistence of efficacy by symptom domain with long-acting injectable paliperidone palmitate in patients with schizophrenia.A further consideration on long-acting injectable versus oral antipsychotics in the treatment of schizophrenia: a narrative review and critical appraisal.Long-Acting Injectable Antipsychotics in Schizophrenia: Literature Review and Practical Perspective, with a Focus on Aripiprazole Once-Monthly.Health care resource utilization and costs of California Medicaid patients with schizophrenia treated with paliperidone palmitate once monthly or atypical oral antipsychotic treatment.Risperidone long-acting injection and 1-year rehospitalization rate of schizophrenia patients: A retrospective cohort study.Comparison and predictors of treatment adherence and remission among patients with schizophrenia treated with paliperidone palmitate or atypical oral antipsychotics in community behavioral health organizations.An open-treatment six-week study of the clinical effectiveness of Paliperidone Palmitate in schizophrenia: data from acute units in Spain (SHADOW study).Adherence, persistence, and inpatient utilization among adult schizophrenia patients using once-monthly versus twice-monthly long-acting atypical antipsychotics.The effects of switching from oral to LAI antipsychotic treatment on subjective experience of schizophrenic and schizoaffective patients: Preliminary results.Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder.A systematic literature review of the clinical and health economic burden of schizophrenia in privately insured patients in the United States.Impact of time of initiation of once-monthly paliperidone palmitate in hospitalized Asian patients with acute exacerbation of schizophrenia: a post hoc analysis from the PREVAIL study.
P2860
Q33650097-50A28FDA-13AB-4CF6-966C-3A15759743D5Q34418847-9B95D821-EEE2-44A6-8094-773D4F8EE9ABQ36412766-974DC199-3E2A-42DE-985F-3CE5598664D9Q36550998-72F39FB4-C18F-45F3-A173-ACDC3C7295D9Q37722508-8B22534F-CF13-435D-9D2E-B216E75C1568Q37733957-9776EC15-B453-4D9A-AD3B-CF9BB7D1ED73Q38206231-78DBC182-1A80-435D-87E1-28CC695ABB36Q38659006-8C872299-D1CA-44F6-A067-26091188D1E8Q38851123-AD92D93B-7BD2-4E1D-B19C-634768FF7099Q39043536-99C7F8E6-EA35-4C7F-A359-0C4C105A66ECQ41204400-F929A605-503E-4F2A-9EE0-F6290D1FE43BQ42659528-4378706C-90B8-4090-9114-41F8F0C8766BQ47434414-E2D0F7EC-C5FC-4710-A913-A52C1396BA6BQ47998008-23AEAB6E-BD42-4CD2-B1B5-92D363E92D81Q48059462-2A1F72DC-DFA0-41D4-978E-7F20FCD8ECEFQ50140700-1EA152D5-031E-41E3-B5C3-776133235D4AQ55161186-53EA7994-111B-46C7-811C-75188D026CD3Q55317641-7006ED54-26E9-4A22-A3EC-0340BA6407DB
P2860
Impact of atypical long-acting injectable versus oral antipsychotics on rehospitalization rates and emergency room visits among relapsed schizophrenia patients: a retrospective database analysis
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Impact of atypical long-acting ...... etrospective database analysis
@ast
Impact of atypical long-acting ...... etrospective database analysis
@en
Impact of atypical long-acting ...... etrospective database analysis
@nl
type
label
Impact of atypical long-acting ...... etrospective database analysis
@ast
Impact of atypical long-acting ...... etrospective database analysis
@en
Impact of atypical long-acting ...... etrospective database analysis
@nl
prefLabel
Impact of atypical long-acting ...... etrospective database analysis
@ast
Impact of atypical long-acting ...... etrospective database analysis
@en
Impact of atypical long-acting ...... etrospective database analysis
@nl
P2093
P2860
P356
P1433
P1476
Impact of atypical long-acting ...... etrospective database analysis
@en
P2093
François Laliberté-Auger
John Fastenau
Marie-Hélène Lafeuille
Mei Sheng Duh
Patrick Lefebvre
P2860
P2888
P356
10.1186/1471-244X-13-221
P577
2013-09-10T00:00:00Z
P5875
P6179
1041743863